Hyundai Pharmaceutical Co Ltd (Hyundai Pharma) is pharmaceutical company that manufactures and distributes pharmaceuticals products, health food and drinks, and medical equipment. The company provides OTC and ETC products. Hyundai Pharma offers OTC products in the areas of anaemia, arthritis, constipation, disinfectant, diagnostic reagent, dermatological reagent, lip care, nutrition and others. It also offers ETC products in the areas of cardio vascular, CNS, digestive system, contraceptives, endocrine and oral diseases. The company’s ETC products are minopecia, cotareg, tareg, xilep, mirap-ER, staretam and others. It was formerly known as Hyundai Disinfection Chemical Industrial Co., Ltd. Hyundai Pharma headquartered in Seoul, South Korea. GlobalData’s Hyundai Pharmaceutical Co Ltd (004310) - Financial and Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years. This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering world’s leading companies.